Screener
NewAmsterdam Pharma Company NAMS Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from NewAmsterdam Pharma Company’s reported figures.
Based on trailing twelve months.
The source filing: NewAmsterdam Pharma Company’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 7:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333824
FAQ
- What is NewAmsterdam Pharma Company's net margin?
- NewAmsterdam Pharma Company (NAMS) reported net margin of -3,644.2% in Q2 2026.
- How has NewAmsterdam Pharma Company's net margin changed year-over-year?
- NewAmsterdam Pharma Company's net margin decreased by 1307.5% year-over-year, from -258.9% to -3,644.2%.
- What is the long-term trend for NewAmsterdam Pharma Company's net margin?
- Over 3 years (2022 to 2025), NewAmsterdam Pharma Company's net margin has grown at a 245.1% compound annual growth rate (CAGR), from -22% to -905.7%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about NewAmsterdam Pharma Company's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude